MDS Virtual Congress 2020 » Parkinson's Disease: Psychiatric Manifestations

Anxiety in Parkinson’s disease is associated with changes in the brain fear circuit

G. Carey, R. Lopes, R. Viard, N. Betrouni, G. Kuchcinski, Q. Devignes, L. Defebvre, A. Leentjens, K. Dujardin (Lille, France)

Association between BDNF Val66Met polymorphism and mild behavioral impairment in patients with Parkinson’s patients

M. Ramezani, J. Ruskey, K. Martens, E. Leveille, Z. Javer, I. Kathol, M. Kibreab, T. Hammer, J. Cheetham, J. Sarna, D. Martino, G. Pfeffer, Z. Gan-Or, Z. Ismail, O. Monchi (Calgary, AB, Canada)

Association between impulse control disorders and depression in drug-naïve Parkinson’s disease

A. Karukote, S. Thakolwiboon, P. Julayanont (Lubbock, TX, USA)

Attitudes of Care Partners Toward Medications for Parkinson’s Disease Psychosis

S. Mantri, S. Albert, E. Klawson, L. Alzyoud, M. Daeschler, C. Kopil, C. Marras, L. Chahine (Toronto, ON, Canada)

Clinical Features of Depressive Disorders in Parkinson’s Disease: Possibilities of their Correction

A. Umarov, G. Rakhimbaeva (Tashkent, Uzbekistan)

Depression in patients with Parkinson’s disease

M. Lisak, B. Špiljak (Zagreb, Croatia)

Fear of progression in Parkinson’s disease: Preliminary results of a pilot cross-sectional study

A. Folkerts, J. Saliger, J. Nielsen, H. Karbe, M. Goosses, V. Vida, C. Trenkwalder, A. Kruse, H. Oelsner, G. Ebersbach, E. Kalbe (Cologne, Germany)

Frequency of Impulse Control Disorders and Other Related Behaviors in People with Parkinson’s Disease

G. Xavier-Souza, A. Mendoza, I. Alves, L. Almeida, G. Valença (Salvador, Brazil)

Homer1 polymorphism in patients with Parkinson’s disease and psychosis

A. Lenka, S. Vadivel, R. Christopher, S. Arumugham, S. Hegde, R. Yadav, P. Pal (Washington, DC, USA)

Identification and Documentation of Delirium in Parkinson’s Disease

R. Cullinan, S. Richardson, A. Yarnall, D. Burn, L. Allan, R. Lawson (Newcastle-Upon-Tyne, United Kingdom)

Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study Update

N. Dissanayaka, G. Byrne, L. Mitchell, J. O'Sullivan, A. Padmassini, E. White, J. Yang, E. Forbes, K. Thangavelu, T. Au, A. Lehn, R. Adam, N. Pachana (Brisbane, Australia)

Impulse control disorder in the patients of Parkinson’s disease: Various correlations

M. Waghralkar, V. Gupta, A. Jukkarwala (Udaipur, India)

Impulse Control Disorders and Other Psychiatric Complications in a Series of Patients Treated Levodopa-Carbidopa Instestinal Gel

A. Contreras, M. Mas, F. Grandas (Madrid, Spain)

Increased illusory responses in non-hallucinating, cognitively impaired Lewy body disease patients

M. Shahid, A. Rawls, V. Ramirez, S. Ryman, V. Santini, L. Yang, S. Sha, J. Hall, T. Montine, L. Tian, B. Cholerton, V. Henderson, M. Yutsis, K. Poston (Stanford, CA, USA)

Increased risk of Parkinson’s disease in patients with schizophrenia spectrum disorders

T. Kuusimäki, H. Al-Abdulrasul, S. Kurki, J. Hietala, S. Hartikainen, M. Koponen, A. Tolppanen, V. Kaasinen (Turku, Finland)

Maladaptive use of LD/CD tablets as painkillers causing Dopamine Dysregulation Syndrome in 4 patients of Advanced Parkinson’s Disease

M. Gautam, K. Shukla, N. Sawal (Chandigarh, India)

Mental Health Matters Too – Integration of physical and mental health in a multidisciplinary Parkinson’s Clinic

C. Taylor, C. Johnson, J. Marsh, L. Brown, A. Silverwood, R. Stringer, C. Cooper, R. Skelly (Derby, United Kingdom)

Minor hallucinations in Parkinson’s disease are associated with increased neurofilament plasma levels and reduced white-matter integrity in the inferior longitudinal fasciculus

H. Bejr-kasem, J. Pagonabarraga, F. Sampedro, S. Martínez-Horta, R. Perez-Gonzalez, J. Marín-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, A. Campolongo, C. Izquierdo, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

Naturalistic study of depression and Parkinson´s Disease in a third level of attention in Mexico City

R. Janssen Aguilar, A. Ruiz Chow, M. Rodriguez Violante, P. Rojas Castañeda, A. Cervantes Arriaga, E. Ruiz Sanchez, Y. Alcantara Flores, A. Marquez Duarte (Mexico City, Mexico)

Neural activity in the subthalamic nucleus in association with reward/loss processing in patients with Parkinson’s disease

CC. Zhang, J. Li, L. Manssuer, Q. Ding, L.B Wang, B.M Sun, D.Y Li, V. Voon (Shanghai, China)

Neuroimaging of anxiety in Parkinson’s disease: a systematic review

G. Carey, M. Görmezoğlu, K. Dujardin, A. Leentjens (Maastricht, Netherlands)

Prevalence, Impact, and Suboptimal Treatment of Depression in the Fox Insight Cohort

R. Dobkin, M. Gara, S. Mann, K. Rodriguez, A. Interian (Piscataway, NJ, USA)

Profiling Atypical Anxiety in Parkinson’s Disease

E. Forbes, G. Byrne, J. O'Sullivan, J. Yang, N. Dissanayaka (St Lucia, Australia)

Psychiatric comorbidities in Young Onset Parkinson’s disease

A. Patwardhan, P. Pal, N. Kamble, R. Yadav (Bangalore, India)

Rates of Pharmacological Treatment of Neuropsychiatric Symptoms in Early Parkinson’s Disease

C. Kulick-Soper, C. Caspell-Garcia, C. Coffey, M. Picillo, D. Weintraub, N. Dahodwala (Philadelphia, PA, USA)

Risk of Suicidal Ideation After Deep Brain Stimulation Surgery in Patients with Parkinson’s Disease

A. Seritan, J. Parad, S. Wang, J. Ostrem, A.M Iosif (San Francisco, CA, USA)

Video-to-Home Cognitive-Behavioral Therapy for Veterans with Depression and Parkinson’s Disease: A Randomized Controlled Trial

R. Dobkin, S. Mann, K. Rodriguez, L. St. Hill, R. Miller, A. King, M. Gara, A. Interian (Piscataway, NJ, USA)